|Bid||0.00 x 1100|
|Ask||0.00 x 800|
|Day's range||299.44 - 310.16|
|52-week range||213.16 - 340.11|
|Beta (5Y monthly)||0.70|
|PE ratio (TTM)||14.48|
|Earnings date||03 Feb 2023|
|Forward dividend & yield||4.48 (1.43%)|
|Ex-dividend date||05 Dec 2022|
|1y target est||359.13|
(Reuters) -Cigna Corp beat Wall Street estimates for quarterly profit on Friday, aided by a sharp fall in medical costs due to lower COVID-19-related hospitalizations. Health insurers have largely managed to keep medical costs in check during the fourth quarter amid a so-called "tripledemic" of an early flu season coinciding with COVID and respiratory syncytial virus cases. Cigna's quarterly medical care ratio, or its spending on claims as a percentage of premiums, declined to 84.0% from 87.0%, and was better than the analysts' average estimate of 84.28%, according to Refinitiv data.
Stride, Herc Holdings, ONEOK and Cigna have been highlighted in this Screen of The Week article.